SITC Cancer Immunotherapy CONNECT


WIN Leadership Institute

The Women in Cancer Immunotherapy Network (WIN) Leadership Institute returns this summer and will grow to two programs, in Seattle (July 13–14) and Chicago (Aug. 3–4).The one-and-a-half-day programs celebrate and empower emerging women leaders in the cancer immunotherapy field.



SITC Fellowships and Award 

This year, SITC is offering young investigators $600,000 in funding to advance their cancer immunotherapy research through six fellowships and a new, unique award.

Interested applicants may apply for more than one opportunity. Applications are due by Friday, Feb. 28, at 5 p.m. PST. 



SITC's Surfaceome Workshop

Attend the SITC Interrogating the Tumor-Specific Surfaceome for Immune Targeting Workshop on April 23–24, 2020, in San Diego.

This workshop will provide an intimate opportunity for attendees to discuss their work with experts in the field. Abstracts are due by Friday, Feb. 28, at 5 p.m. PST. Encore presentations welcome!



Why I'm a SITC Member

Join Jennifer Guerriero, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.

Become a SITC Member

Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program 

Tucson, Ariz. on March 14


Seattle on march 28

Toronto on April 9




SITC 2019 Quality Summit Consensus Report

Read the manuscript, Defining Current Gaps in Quality Measures for Cancer Immunotherapy: Consensus Report from the Society for Immunotherapy of Cancer (SITC) 2019 Quality Summit, as published in the Journal for ImmunoTherapy of Cancer.

Read the JITC Article

Now Available: SITC Consensus Statement on Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma

New Online Patient Course Available: Understanding Cancer Immunotherapy 
Access SITC’s dedicated resource for patients and caregivers to learn about cancer immunotherapy


Toxicity Management Course 

A free, interactive course, part of the Advances in Cancer Immunotherapy™ online education series.

Register Now


2020 Multidisciplinary Head and Neck Cancers Symposium

Attend the symposium Feb. 27–29, 2020, in Scottsdale, Ariz. This practical and interactive meeting is for the entire head and neck cancer care community.

Register to Attend Today


Meet-the-Expert Webinar: Leadership

SITC is pleased to host "Meet-the-Expert Webinar: Leadership" on Thursday, March 12, 2020, from 3–4 p.m. EST. This one-hour webinar moderated by Sarah Church, PhD – NanoString Technologies, and presented by Alessandra Cesano, MD, PhD (ESSA Pharma Inc.), will discuss leadership skills along with strategies and tactics for developing your team. 



National Congress: Molecular Medicine - From Laboratory to Practice 

The Institute of Molecular Medicine & Biomedical Research and SITC will co-organize a joint education symposium on the Basics of Immunotherapy at the national congress in Athens, Greece from March 1214, 2020.

Register to Attend Today


Immunotherapy of Cancer Conference 

The 7th Immunotherapy of Cancer Conference (ITOC7), being held in Munich, Germany from April 2–4, 2020, is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. SITC members receive discounted online registration. 

Register to Attend Today


2020 RSS Annual Scientific Meeting: SITC Session

The Radiosurgery Society Annual Scientific Meeting takes place from April 2–4, 2020, in Washington, D.C. As part of the scientific program, a joint session hosted by the RSS in collaboration with SITC on Current Trials on the Combination of Stereosactic Radiotherapy with Immunotherapy for the Treatment of Cancer.

Register to Attend Today


Explore resources and educational opportunities for cancer patients and those who advocate for them.







Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.







Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.






Latest Discussions

  • Profile Picture

    RE: Vitrakvi

    On November 26, 2018, the Food and Drug Administration granted accelerated approval to larotrectinib (VITRAKVI, Loxo Oncology Inc. and Bayer) for adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene ...

  • Profile Picture


    Please send any information of this drug Thank in advance Sent from my iPhone

  • Join more than 50 stellar speakers at AI and Big Data in Cancer (March 29-31, 2020, Boston) to explore a pragmatic approach to effectively translate technology, data and analytic innovations into clinical practices and patient benefit.  An exceptional ...

    1 person recommends this.

Follow the SITC Twitter Feed.


Connect with colleagues at these Upcoming Events.


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.


Learn More


The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More